Chapter 35: Molecular Imaging Using Nanobodies: A Case Study

Nick Devoogdt; Catarina Xavier; Sophie Hernot; Ilse Vaneycken; Matthias D'huyvetter; Jens De Vos; Sam Massa; Patrick De Baetselier; Vicky Caveliers; Tony Lahoutte; Nathalie Impens; An Aerts; Sarah Baatout

Chapter 35: Molecular Imaging Using Nanobodies: A Case Study

Nick Devoogdt, Catarina Xavier, Sophie Hernot, Ilse Vaneycken, Matthias D'huyvetter, Jens De Vos, Sam Massa, Patrick De Baetselier, Vicky Caveliers, Tony Lahoutte, Nathalie Impens, An Aerts, Sarah Baatout

Radiobiology

Research output › peer-review

Abstract

Molecular imaging is a noninvasive method to measure specific biological processes in animal models and patients using imaging. In recent years there has been a tremendous evolution in hardware and software for imaging purposes. This progress has created an urgent need for new labeled targeted molecular probes. The unique physicochemical and pharmacokinetic properties of Nanobodies match the requirements of the ideal molecular imaging tracer. Preclinical studies show strong and specific targeting in vivo with rapid clearance of unbound probe resulting in high contrasted images at early time points after intravenous administration. These data suggest that the Nanobody platform might become a generic method for the development of next generation molecular imaging probes.

Original language	English
Title of host publication	Singe Domain Antibodies, Methods and Protocols
Place of Publication	Springer New York Heidelberg Dordrecht London, United States
Publisher	Springer
Pages	559-567
Edition	1
ISBN (Print)	978-1-61779-968-6
State	Published - Jan 2012

Publication series

Name	Methods in Molecular Biology
Number	911

Cite this

Devoogdt, N., Xavier, C., Hernot, S., Vaneycken, I., D'huyvetter, M., De Vos, J., Massa, S., De Baetselier, P., Caveliers, V., Lahoutte, T., Impens, N., Aerts, A., & Baatout, S. (2012). Chapter 35: Molecular Imaging Using Nanobodies: A Case Study. In Singe Domain Antibodies, Methods and Protocols (1 ed., pp. 559-567). (Methods in Molecular Biology; No. 911). Springer.

Devoogdt, Nick ; Xavier, Catarina ; Hernot, Sophie ; Vaneycken, Ilse ; D'huyvetter, Matthias ; De Vos, Jens ; Massa, Sam ; De Baetselier, Patrick ; Caveliers, Vicky ; Lahoutte, Tony ; Impens, Nathalie ; Aerts, An ; Baatout, Sarah. / Chapter 35: Molecular Imaging Using Nanobodies: A Case Study. Singe Domain Antibodies, Methods and Protocols. 1. ed. Springer New York Heidelberg Dordrecht London, United States : Springer, 2012. pp. 559-567 (Methods in Molecular Biology; 911).

@inbook{f890cbaca0ec497cab504bbb69f00adc,

title = "Chapter 35: Molecular Imaging Using Nanobodies: A Case Study",

abstract = "Molecular imaging is a noninvasive method to measure specific biological processes in animal models and patients using imaging. In recent years there has been a tremendous evolution in hardware and software for imaging purposes. This progress has created an urgent need for new labeled targeted molecular probes. The unique physicochemical and pharmacokinetic properties of Nanobodies match the requirements of the ideal molecular imaging tracer. Preclinical studies show strong and specific targeting in vivo with rapid clearance of unbound probe resulting in high contrasted images at early time points after intravenous administration. These data suggest that the Nanobody platform might become a generic method for the development of next generation molecular imaging probes.",

keywords = "Molecular imaging, Biodistribution, SPECT, PET, Radiochemistry, Radionuclide",

author = "Nick Devoogdt and Catarina Xavier and Sophie Hernot and Ilse Vaneycken and Matthias D'huyvetter and {De Vos}, Jens and Sam Massa and {De Baetselier}, Patrick and Vicky Caveliers and Tony Lahoutte and Nathalie Impens and An Aerts and Sarah Baatout",

note = "Score = 3",

year = "2012",

month = jan,

language = "English",

isbn = "978-1-61779-968-6",

series = "Methods in Molecular Biology",

publisher = "Springer",

number = "911",

pages = "559--567",

booktitle = "Singe Domain Antibodies, Methods and Protocols",

edition = "1",

}

Devoogdt, N, Xavier, C, Hernot, S, Vaneycken, I, D'huyvetter, M, De Vos, J, Massa, S, De Baetselier, P, Caveliers, V, Lahoutte, T, Impens, N, Aerts, A & Baatout, S 2012, Chapter 35: Molecular Imaging Using Nanobodies: A Case Study. in Singe Domain Antibodies, Methods and Protocols. 1 edn, Methods in Molecular Biology, no. 911, Springer, Springer New York Heidelberg Dordrecht London, United States, pp. 559-567.

Chapter 35: Molecular Imaging Using Nanobodies: A Case Study. / Devoogdt, Nick; Xavier, Catarina; Hernot, Sophie; Vaneycken, Ilse; D'huyvetter, Matthias; De Vos, Jens; Massa, Sam; De Baetselier, Patrick; Caveliers, Vicky; Lahoutte, Tony; Impens, Nathalie (null); Aerts, An (null); Baatout, Sarah (null).

Singe Domain Antibodies, Methods and Protocols. 1. ed. Springer New York Heidelberg Dordrecht London, United States : Springer, 2012. p. 559-567 (Methods in Molecular Biology; No. 911).

Research output › peer-review

TY - CHAP

T1 - Chapter 35: Molecular Imaging Using Nanobodies: A Case Study

AU - Devoogdt, Nick

AU - Xavier, Catarina

AU - Hernot, Sophie

AU - Vaneycken, Ilse

AU - D'huyvetter, Matthias

AU - De Vos, Jens

AU - Massa, Sam

AU - De Baetselier, Patrick

AU - Caveliers, Vicky

AU - Lahoutte, Tony

A2 - Impens, Nathalie

A2 - Aerts, An

A2 - Baatout, Sarah

N1 - Score = 3

PY - 2012/1

Y1 - 2012/1

N2 - Molecular imaging is a noninvasive method to measure specific biological processes in animal models and patients using imaging. In recent years there has been a tremendous evolution in hardware and software for imaging purposes. This progress has created an urgent need for new labeled targeted molecular probes. The unique physicochemical and pharmacokinetic properties of Nanobodies match the requirements of the ideal molecular imaging tracer. Preclinical studies show strong and specific targeting in vivo with rapid clearance of unbound probe resulting in high contrasted images at early time points after intravenous administration. These data suggest that the Nanobody platform might become a generic method for the development of next generation molecular imaging probes.

AB - Molecular imaging is a noninvasive method to measure specific biological processes in animal models and patients using imaging. In recent years there has been a tremendous evolution in hardware and software for imaging purposes. This progress has created an urgent need for new labeled targeted molecular probes. The unique physicochemical and pharmacokinetic properties of Nanobodies match the requirements of the ideal molecular imaging tracer. Preclinical studies show strong and specific targeting in vivo with rapid clearance of unbound probe resulting in high contrasted images at early time points after intravenous administration. These data suggest that the Nanobody platform might become a generic method for the development of next generation molecular imaging probes.

KW - Molecular imaging

KW - Biodistribution

KW - SPECT

KW - PET

KW - Radiochemistry

KW - Radionuclide

UR - http://ecm.sckcen.be/OTCS/llisapi.dll/open/ezp_128837

UR - http://knowledgecentre.sckcen.be/so2/bibref/10215

M3 - Chapter

SN - 978-1-61779-968-6

T3 - Methods in Molecular Biology

SP - 559

EP - 567

BT - Singe Domain Antibodies, Methods and Protocols

PB - Springer

CY - Springer New York Heidelberg Dordrecht London, United States

ER -